Products Categories
| CAS No.: | 31793-07-4 |
|---|---|
| Name: | Pirprofen |
| Molecular Structure: | |
|
|
|
| Formula: | C13H14 Cl N O2 |
| Molecular Weight: | 251.713 |
| Synonyms: | Hydratropicacid, 3-chloro-4-(3-pyrrolin-1-yl)- (8CI); (?à)-Pirprofen; 2-[3-Chloro-4-(2,5-dihydropyrrol-1-yl)-phenyl]propanoicacid; 2-[3-Chloro-4-(3-pyrrolin-1-yl)phenyl]propionic acid;3-Chloro-4-(3-pyrrolin-1-yl)hydratropic acid; Pirprofen; Racemic pirprofen;Rangasil 400; Rengasil; Seflenyl; Su 21524 |
| Density: | 1.298g/cm3 |
| Melting Point: | 98-100° |
| Boiling Point: | 410.8°Cat760mmHg |
| Flash Point: | 202.2°C |
| Safety: | Poison by ingestion and intravenous routes. When heated to decomposition it emits toxic fumes of Cl− and NOx. |
| PSA: | 40.54000 |
| LogP: | 2.96930 |
Empirical Formula: C13H14ClNO2
Molecular Weight: 251.7088 g/mol
EINECS: 250-805-8
Index of Refraction: 1.604
Density: 1.298 g/cm3
Flash Point: 202.2 °C
Enthalpy of Vaporization: 69.93 kJ/mol
Boiling Point: 410.8 °C at 760 mmHg
Vapour Pressure: 1.74E-07 mmHg at 25 °C
Structure of Pirprofen (CAS NO.31793-07-4):
.png)
IUPAC Name of Pirprofen (CAS NO.31793-07-4): 2-[3-Chloro-4-(2,5-dihydropyrrol-1-yl)phenyl]propanoic acid
Pirprofen (CAS NO.31793-07-4) has been used as a non-steroidal anti-inflammatory drug.
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| guinea pig | LD50 | oral | 193mg/kg (193mg/kg) | Archives of Toxicology, Supplement. Vol. 7, Pg. 365, 1984. | |
| hamster | LD50 | oral | 1190mg/kg (1190mg/kg) | Archives of Toxicology, Supplement. Vol. 7, Pg. 365, 1984. | |
| mouse | LD50 | intraperitoneal | 1300mg/kg (1300mg/kg) | Russian Pharmacology and Toxicology Vol. 49, Pg. 98, 1986. | |
| mouse | LD50 | oral | 1350mg/kg (1350mg/kg) | Archives of Toxicology, Supplement. Vol. 7, Pg. 365, 1984. | |
| rat | LD50 | intravenous | 167mg/kg (167mg/kg) | GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE GASTROINTESTINAL: ULCERATION OR BLEEDING FROM LARGE INTESTINE | Current Therapeutic Research, Clinical & Experimental. Vol. 30(Suppl, |
| rat | LD50 | oral | 351mg/kg (351mg/kg) | GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE GASTROINTESTINAL: ULCERATION OR BLEEDING FROM LARGE INTESTINE | Current Therapeutic Research, Clinical & Experimental. Vol. 30(Suppl, |
| women | LDLo | oral | 864mg/kg/54D- (864mg/kg) | BEHAVIORAL: COMA LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" | Netherlands Journal of Medicine. Vol. 37, Pg. 32, 1990. |
| women | LDLo | oral | 3488mg/kg/31W (3488mg/kg) | LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" | Gastroenterology. Vol. 89, Pg. 210, 1985. |
| women | TDLo | oral | 4624mg/kg/41W (4624mg/kg) | LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" | Gastroenterology. Vol. 89, Pg. 210, 1985. |
Poison by ingestion and intravenous routes. When heated to decomposition it emits toxic fumes of Cl− and NOx.
Pirprofen ,its cas register number is 31793-07-4. It also can be called Pirprofeno ; Pirprofenum ; Rengasil ; and 3-Chloro-4-(2,5-dihydro-1H-pyrrol-1-yl)-a-methylbenzeneacetic Acid .